Holen Sie sich die Stockscreener-App
93.61
0.06%
0.06
Handel nachbörslich:
93.61
Boston Scientific Corp Aktie (BSX) Neueste Nachrichten
Boston Scientific completes Nalu Medical acquisition - MassDevice
Transcatheter Embolization and Occlusion Devices Market Size to be Valued at USD 11.53 Billion by 2033, Driven by Rising Oncology and Neurovascular Interventions – SNS Insider - GlobeNewswire Inc.
Boston Scientific (BSX) stock ticks higher again — what to watch before Tuesday’s trade - TechStock²
Boston Scientific to acquire Alameda-based Penumbra for $14.5 billion - MSN
Boston Scientific (BSX) Sees Surge in Call Options Activity - GuruFocus
Boston Scientific stock rises as Evercore taps BSX for a tactical list ahead of earnings - TechStock²
Lbp Am Sa Increases Position in Boston Scientific Corporation $BSX - MarketBeat
Evercore ISI reiterates Outperform rating on Boston Scientific stock - Investing.com
Hospitals are embracing pulsed field ablation. Here’s why - Modern Healthcare News
Algebris UK Ltd. Invests $1.77 Million in Boston Scientific Corporation $BSX - MarketBeat
Mitsubishi UFJ Trust & Banking Corp Has $72.29 Million Stake in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific stock navigates a cautious upswing as Wall Street leans bullish - AD HOC NEWS
UniSuper Management Pty Ltd Boosts Holdings in Boston Scientific Corporation $BSX - MarketBeat
What Does the Market Think About Boston Scientific Corp? - Sahm
Oppenheimer Questions Valuation of Boston Scientific's $14.5 Billion Penumbra Deal - Finviz
Oppenheimer Questions Valuation of Boston Scientific’s $14.5 Billion Penumbra Deal - Yahoo Finance
Boston Scientific stock price: BSX ends higher as Fitch turns credit outlook positive ahead of key catalysts - TechStock²
Boston Scientific (BSX) Exceeds Market Returns: Some Facts to Consider - Yahoo Finance
Boston Scientific ratings affirmed by Fitch, outlook positive - Investing.com
Boston Scientific stock (BSX) climbs as heart-rhythm rivalry and deal risk stay in play - TechStock²
Teacher Retirement System of Texas Has $77.67 Million Stake in Boston Scientific Corporation $BSX - MarketBeat
iA Global Asset Management Inc. Acquires 31,717 Shares of Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corporation (NYSE:BSX) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX) and ACADIA Pharmaceuticals (ACAD) - The Globe and Mail
Oppenheimer Questions $14.5B Penumbra Deal Valuation Despite Boston Scientific's (BSX) Mew Market Dominance - Finviz
A Closer Look at Boston Scientific's Options Market Dynamics - Benzinga
Boston Scientific announces agreement to acquire Penumbra, Inc. - Quantisnow
Boston Scientific Corporation (NYSE:BSX) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap? - Yahoo Finance
Boston Sci secures CE mark for Embold system - BioWorld MedTech
Boston Scientific Advises Removal Of Certain AXIOS Stents After Deployment Issues Surface - Benzinga
Boston Scientific (BSX) to acquire Penumbra in $14.5B neurovascular push - Stock Titan
Universal Beteiligungs und Servicegesellschaft mbH Reduces Holdings in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific (BSX): Company Profile, Stock Price, News, Rankings - Fortune
Boston Scientific to acquire Penumbra (NYSE: PEN) in $14.5B deal - Stock Titan
Investors Purchase Large Volume of Call Options on Boston Scientific (NYSE:BSX) - MarketBeat
Boston Scientific stock rises as BSX teases new pain-therapy data while FDA stent alert hangs over shares - TechStock²
Boston Scientific has a potentially serious Axios stent recall - MassDevice
Boston Scientific stock rating reiterated at Outperform by Mizuho - Investing.com
Boston Scientific recalls stent over issue linked to 3 deaths - MedTech Dive
3 takeaways from Boston Scientific’s $14.5B Penumbra deal - MedTech Dive
Boston Scientific to Acquire Alameda-Based Penumbra for $14.5 Billion - alamedapost.com
Analysts Are Bullish on These Healthcare Stocks: Henry Schein (HSIC), Boston Scientific (BSX) - The Globe and Mail
Canaccord Genuity downgrades Penumbra stock to Hold after Boston Scientific deal - Investing.com
Penumbra shares soar pre-market — what is the Boston Scientific agreement? - MSN
Boston Scientific to Acquire Penumbra - Diagnostic and Interventional Cardiology
Boston Scientific’s Strategic Acquisition Tests Investor Resolve - AD HOC NEWS
Allstate Corp Has $5.31 Million Stake in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific to acquire Penumbra, expanding cardiovascular portfolio - Today's Medical Developments
Penumbra Shares Soar Pre-MarketWhat Is The Boston Scientific Agreement? - Menafn
UnitedHealth Stock Slips Amid Medicare Investigation; Boston Scientific to Acquire Penumbra for $14.5B - Intellectia AI
Is Boston Scientific Corporation (NYSE:BSX) Worth US$88.1 Based On Its Intrinsic Value? - Yahoo Finance
Boston Scientific (BSX) Expands Urology Portfolio with Valencia Deal, Analysts Emphasize Organic Growth - Insider Monkey
Sen. Markwayne Mullin Purchases Shares of Boston Scientific Corporation (NYSE:BSX) - MarketBeat
A big acquisition decades ago almost broke Boston Scientific. Its CEO says this time is different. - Star Tribune
Med tech company Boston Scientific readies for new Austin offices - MSN
RTW Biotech Opp.Boston Scientific to acquire Penumbra - Research Tree
0.68%
0.02%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):